Speakers

Expand/Collapse

Tom Thattacherry
Head of Supplier Diversity
Roche/ Genentech

Day Two

12:50 pm | Benefits of Supplier Diversity from Morals to Macroeconomics

Aaron Nolan
Consultant, Clinical Labs and Diagnostic Technologies
Eli Lilly and Company

Day One

9:30 am | Case Study on Supplier Spend Analytics for Clinical Trials

David Karakas
Director, Sourcing & Procurement
Bluebird Bio

Day One

2:15 pm | Strategic Sourcing for Rare Diseases & Emerging Therapeutics

Rinaldo Dorman
Senior Manager, R&D Global Procurement & Strategic Sourcing
Sarepta Therapeutics

Day One

4:45 pm | Speaker Interview Followed by Debate: Single vs Dual vs TriSourcing – How Takeda Realigned their Sourcing Strategy Post Shire Acquisition

Day Two

2:31 pm | Discussion: Vendor Oversight and Risk Management Approaches Across the Pharma Industry

Gerard Cardillo
Executive Director Global Categories Procurement
Charles River Labs

Day One

2:35 pm | Importance of Pre-Emptive Thinking in Procurement of NHP’s for Ultimate Product Approval

12:00 pm | Effects of Covid-19 on Procurement and Sourcing

Penelope Przekop
CEO
PDC Pharma Strategy

Day Two

2:31 pm | Discussion: Vendor Oversight and Risk Management Approaches Across the Pharma Industry

Limor Glick
Executive Director, Head of Global Strategic Sourcing
Corbus Pharmaceuticals

Day Two

2:31 pm | Discussion: Vendor Oversight and Risk Management Approaches Across the Pharma Industry

Farah Ahmad
Chief Commercial Officer
Clinical Maestro

Day One

2:55 pm | Technology Booms In Business Operations; A Case Study in RFP Automation

Wanlu Liu
Global Lead Sourcing Manager
Takeda

Day One

4:45 pm | Speaker Interview Followed by Debate: Single vs Dual vs TriSourcing – How Takeda Realigned their Sourcing Strategy Post Shire Acquisition

Deborah Franco
Global Sourcing Manager Scientific Services
Novartis

Day One

9:10 am | Optimizing R&D Costs with Machine Learning: How A Big Pharma Diagnoses & Improves Research Efficiency with AI-Assisted Reagent Selection

Rose Prisco
Associate Director Clinical Procurement
Pacira Pharmaceuticals

Day Two

9:50 am | Contracting – Who Drives the Content

Martisse Best
Senior Director, Strategic Sourcing
IQVIA

Day One

12:00 pm | Effects of Covid-19 on Procurement and Sourcing

10:40 am | Models, challenges and Triumphs of a Virtual Trial

Victoria Woodward
Procurement Professional
Indivior

Day One

12:00 pm | Effects of Covid-19 on Procurement and Sourcing

Day Two

11:50 am | Mastermind: Forging the Next Generation of Procurement Professionals in R&D – What is the Ideal Procurement Resume?

Mark Davis
Founder & Principal
NegotiumBio

Day One

12:00 pm | Effects of Covid-19 on Procurement and Sourcing

5:25 pm | Chair’s Closing Remarks

9:00 am | Chair’s Opening Address

Day Two

3:30 pm | Supplier Relationship Management Deep Dive (Locked Content see Post-Conference Deep Dive)

3:15 pm | Chair’s Closing Remarks - Join us for the Deep Dive to Continue your Learning

9:20 am | Chair’s Opening Remarks

2:31 pm | Discussion: Vendor Oversight and Risk Management Approaches Across the Pharma Industry

Erin Benson
Director Market Planning
LexisNexis Risk Solutions

Day One

12:45 pm | Program Partner: LexisNexis

Tom Heck
Senior Vice President, Clinical Trial Services
TrialCard

Day One

4:30 pm | Proven Technology Driven Clinical Trial Supply Alternative

Thierry Fausten
Founder
Informed Decisions GmbH

Day Two

9:30 am | Bridging the Gap Between Pre-Clinical and Clinical: How Early Stakeholder Engagement Aids SRM in Achieving End-to-End Business Development

Siamak Baharloo
CEO & Co-Founder
LabViva

Day One

10:10 am | Buyer-Focused Private Marketplace Procurement: How Novel Solutions Are Shifting Power to Buyers While Aligning the Interests of Both Buyer & Supplier?

Senior Representative

Jaggaer

Day Two

10:10 am | Session Reserved for Jaggaer

Imants Zudans
CEO
MolPort

Day Two

12:30 pm | Session Reserved for Innovation Partner - MolPort